These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 19122155)
61. Impact of stentless aortic valves on left ventricular function and hypertrophy: current best available evidence. Raja SG; Macarthur KJ; Pollock JC J Card Surg; 2006; 21(3):313-9. PubMed ID: 16684073 [TBL] [Abstract][Full Text] [Related]
66. Aortic Valve Replacement With the Stentless Freedom SOLO Bioprosthesis: A Systematic Review. Wollersheim LW; Li WW; Bouma BJ; Repossini A; van der Meulen J; de Mol BA Ann Thorac Surg; 2015 Oct; 100(4):1496-504. PubMed ID: 26324106 [TBL] [Abstract][Full Text] [Related]
67. [Selection of artificial valve for aortic valve disease: mechanical prosthesis versus bioprosthesis]. Kawachi K Nihon Geka Gakkai Zasshi; 2007 Mar; 108(2):58. PubMed ID: 17405537 [No Abstract] [Full Text] [Related]
69. Is early antithrombotic therapy necessary in bioprosthetic valves? Mestres CA; Aramendi JI J Thorac Cardiovasc Surg; 2010 Sep; 140(3):724-5; author reply 725-6. PubMed ID: 20723739 [No Abstract] [Full Text] [Related]
70. Statins may not prevent structural valve degeneration of aortic bioprosthetic valves, but should probably be prescribed to patients undergoing heart valve surgery nonetheless. Paraskevas KI; Mikhailidis DP Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):302. PubMed ID: 20719912 [No Abstract] [Full Text] [Related]
71. Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen? Owais T; Rouman M; Breuer M; Hüter L; Fuchs J; Lauer B; Kuntze T J Heart Valve Dis; 2016 Mar; 25(2):139-144. PubMed ID: 27989055 [TBL] [Abstract][Full Text] [Related]
72. Feasibility of cardiovascular magnetic resonance to assess the orifice area of aortic bioprostheses. von Knobelsdorff-Brenkenhoff F; Rudolph A; Wassmuth R; Bohl S; Buschmann EE; Abdel-Aty H; Dietz R; Schulz-Menger J Circ Cardiovasc Imaging; 2009 Sep; 2(5):397-404, 2 p following 404. PubMed ID: 19808628 [TBL] [Abstract][Full Text] [Related]
73. Stentless 3F Therapeutics Aortic Bioprosthesis--a new alternative to aortic valve replacement. Sadowski J; Kapelak B; Bartuś K; Myć J; Drwita R Acta Cardiol; 2004 Apr; 59(2):231-2. PubMed ID: 15139692 [No Abstract] [Full Text] [Related]
74. Unusual complication after aortic valve replacement with the Freedom Solo stentless bioprosthesis. Celiento M; Scioti G; Pratali S; Guarracino F; Bortolotti U J Heart Valve Dis; 2011 Sep; 20(5):604-6. PubMed ID: 22066371 [TBL] [Abstract][Full Text] [Related]
75. A randomized comparison of the Cryolife O'Brien and Toronto stentless replacement aortic valves. Chambers JB; Rimington HM; Rajani R; Hodson F; Shabbo F J Thorac Cardiovasc Surg; 2007 Apr; 133(4):1045-50. PubMed ID: 17382651 [TBL] [Abstract][Full Text] [Related]
76. Valvular disease: The private life of tissue valves. Yacoub MH; El-Hamamsy I Nat Rev Cardiol; 2010 Aug; 7(8):424-6. PubMed ID: 20657610 [No Abstract] [Full Text] [Related]
77. Percutaneous aortic valve replacement: an important advance in cardiology. Berry D Eur Heart J; 2009 Sep; 30(18):2167-9. PubMed ID: 19752041 [No Abstract] [Full Text] [Related]
78. [Correction of the aortic valve without a prosthesis]. Verkkala K; Heikkilä L Duodecim; 1999; 115(2):197-202. PubMed ID: 11830851 [No Abstract] [Full Text] [Related]